Literature DB >> 2802550

Topical delivery of liposomally encapsulated interferon evaluated in a cutaneous herpes guinea pig model.

N Weiner1, N Williams, G Birch, C Ramachandran, C Shipman, G Flynn.   

Abstract

The topical delivery of liposomally encapsulated interferon was evaluated in the cutaneous herpes simplex virus guinea pig model. Application of liposomally entrapped interferon caused a reduction of lesion scores, whereas application of interferon formulated as a solution or as an emulsion was ineffective. The method of liposomal preparation rather than the lipid composition of the bilayers appeared to be the most important factor for reducing lesion scores. Only liposomes prepared by the dehydration-rehydration method were effective. This finding implied that the dehydration and subsequent rehydration of the liposomes facilitate partitioning of the interferon into liposomal bilayers, where the drug is positioned for transfer into the lipid compartment of the stratum corneum. Liposomes do not appear to function as permeation enhancers but seem to provide the needed physicochemical environment for transfer of interferon into the skin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2802550      PMCID: PMC172628          DOI: 10.1128/AAC.33.8.1217

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

1.  A microplaque reduction assay for human and mouse interferon.

Authors:  J B Campbell; T Grunberger; M A Kochman; S L White
Journal:  Can J Microbiol       Date:  1975-08       Impact factor: 2.419

2.  Fusion patterns of liposomes formed from stratum corneum lipids.

Authors:  W Abraham; P W Wertz; D T Downing
Journal:  J Invest Dermatol       Date:  1988-03       Impact factor: 8.551

3.  Binding and capture of human interferon-alpha by reverse evaporation vesicles, multilamellar vesicles, and small unilamellar vesicles.

Authors:  D A Eppstein; W E Stewart
Journal:  J Interferon Res       Date:  1981

4.  Altered pharmacologic properties of liposome-associated human interferon-alpha. II.

Authors:  D A Eppstein
Journal:  J Interferon Res       Date:  1982

5.  Liposomes--a selective drug delivery system for the topical route of administration. Lotion dosage form.

Authors:  M Mezei; V Gulasekharam
Journal:  Life Sci       Date:  1980-05-05       Impact factor: 5.037

6.  Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root.

Authors:  G J Pazin; J A Armstrong; M T Lam; G C Tarr; P J Jannetta; M Ho
Journal:  N Engl J Med       Date:  1979-08-02       Impact factor: 91.245

7.  Comparison of lymphatic uptake, metabolism, excretion, and biodistribution of free and liposome-entrapped [14C]cytosine beta-D-arabinofuranoside following intraperitoneal administration to rats.

Authors:  R J Parker; E R Priester; S M Sieber
Journal:  Drug Metab Dispos       Date:  1982 Jan-Feb       Impact factor: 3.922

8.  Comparison of the therapeutic effects of five antiviral agents on cutaneous herpesvirus infection in guinea pigs.

Authors:  S Alenius; B Oberg
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

Review 9.  The clinical use of human leukocyte interferon in viral infections.

Authors:  D Ikić; D Trajer; K Cupak; I Petricević; M Prazić; I Soldo; D Jusic; S Smerdel; E Soos
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1981-11

Review 10.  Genital herpes simplex.

Authors:  I S Tummon; D K Dudley; J H Walters
Journal:  Can Med Assoc J       Date:  1981-07-01       Impact factor: 8.262

View more
  9 in total

1.  Liposome associated interferon-alpha-2b functions as an anti-fibrogenic factor in dermal wounds in the guinea pig.

Authors:  A Ghahary; E E Tredget; Q Shen; R T Kilani; P G Scott; M Takeuchi
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

2.  Transport of biologically active interferon-gamma across human skin in vitro.

Authors:  S M Short; W Rubas; B D Paasch; R J Mrsny
Journal:  Pharm Res       Date:  1995-08       Impact factor: 4.200

3.  Topical delivery of liposomally encapsulated interferon evaluated by in vitro diffusion studies.

Authors:  K Egbaria; C Ramachandran; D Kittayanond; N Weiner
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

4.  Formulation and optimization of Zidovudine niosomes.

Authors:  Kandasamy Ruckmani; Veintramuthu Sankar
Journal:  AAPS PharmSciTech       Date:  2010-07-16       Impact factor: 3.246

Review 5.  Liposomes for atopic dry skin: the rationale for a promising approach.

Authors:  M H Schmid; H C Korting
Journal:  Clin Investig       Date:  1993-08

6.  Liposomal tretinoin for uncomplicated acne vulgaris.

Authors:  M Schäfer-Korting; H C Korting; E Ponce-Pöschl
Journal:  Clin Investig       Date:  1994-12

7.  Anti-inflammatory activity of hamamelis distillate applied topically to the skin. Influence of vehicle and dose.

Authors:  H C Korting; M Schäfer-Korting; H Hart; P Laux; M Schmid
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Ascorbic acid encapsulated into negatively charged liposomes exhibits increased skin permeation, retention and enhances collagen synthesis by fibroblasts.

Authors:  Lorena Maione-Silva; Elisandra Gava de Castro; Thais Leite Nascimento; Emílio Ramos Cintra; Larissa Cleres Moreira; Bertilha Alves Santana Cintra; Marize Campos Valadares; Eliana Martins Lima
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

Review 9.  Recurrent and Sustained Viral Infections in Primary Immunodeficiencies.

Authors:  Melanie A Ruffner; Kathleen E Sullivan; Sarah E Henrickson
Journal:  Front Immunol       Date:  2017-06-19       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.